Literature DB >> 9870252

Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.

T Haque1, D H Crawford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9870252     DOI： 10.1007/bf00838050

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  55 in total

1.  Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.

Authors:  I Bourgault; A Gomez; E Gomard; J P Levy
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

2.  Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus.

Authors:  J H Pope; M K Horne; W Scott
Journal:  Int J Cancer       Date:  1968-11-15       Impact factor: 7.396

3.  Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft.

Authors:  D H Crawford; J A Thomas; G Janossy; P Sweny; O N Fernando; J F Moorhead; J H Thompson
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

4.  Involvement of the gastrointestinal tract by Epstein-Barr virus--associated posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik
Journal:  Am J Surg Pathol       Date:  1990       Impact factor: 6.394

5.  Epstein-Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4.

Authors:  H Cen; M C Breinig; R W Atchison; M Ho; J L McKnight
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.

Authors:  A Savoie; C Perpête; L Carpentier; J Joncas; C Alfieri
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

7.  A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder.

Authors:  E J Alfrey; A L Friedman; R A Grossman; L J Perloff; A Naji; C F Barker; K T Montone; J E Tomaszewski; C Chmielewski; T Holland
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

8.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

9.  A novel form of Epstein-Barr virus latency in normal B cells in vivo.

Authors:  E M Miyashita; B Yang; K M Lam; D H Crawford; D A Thorley-Lawson
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

10.  Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.

Authors:  N M Steven; N E Annels; A Kumar; A M Leese; M G Kurilla; A B Rickinson
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307
View more
  2 in total

1.  Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.

Authors:  Arwa Nada; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2021-09-06       Impact factor: 3.651

2.  Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.

Authors:  A E Greijer; S J Stevens; S A Verkuijlen; H Juwana; S C Fleig; E A Verschuuren; B G Hepkema; J J Cornelissen; R A Brooimans; L F Verdonck; J M Middeldorp
Journal:  Clin Dev Immunol       Date:  2012-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.